Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Welsch

Showing results (21-30 of 98) with videos related to

Pageof 10
Sort By:
Bio Systems|August 13, 2025
Computational analysis of IL-6/IL-22 signaling in liver diseaseMarcus D Keßler, Lara Klemt, Marius Kirchner, et al.
The Journal of Clinical Endocrinology and Metabolism|November 27, 2020
Salt-Losing 21-Hydroxylase Deficiency Caused by Double Homozygosity for Two "Mild" MutationsJacob Ilany, Jiayan Liu, Christoph Welsch, et al.
BMC Endocrine Disorders|March 15, 2022
Distinct clinical phenotypes in a family with a novel truncating MEN1 frameshift mutationChristoph Welsch, Anna Katharina Flügel, Susanne Rondot, et al.
Gastroenterology|November 9, 2010
Protease inhibitor-resistant hepatitis C virus mutants with reduced fitness from impaired production of infectious virusTetsuro Shimakami, Christoph Welsch, Daisuke Yamane, et al.
Scientific Reports|January 21, 2016
Natural HCV variants with increased replicative fitness due to NS3 helicase mutations in the C-terminal helix α18Claudia Stross, Tetsuro Shimakami, Katrin Haselow, et al.
Antimicrobial Agents and Chemotherapy|January 19, 2012
Ketoamide resistance and hepatitis C virus fitness in val55 variants of the NS3 serine proteaseChristoph Welsch, Sabine Schweizer, Tetsuro Shimakami, et al.
Plos Pathogens|May 30, 2013
Class A scavenger receptor 1 (MSR1) restricts hepatitis C virus replication by mediating toll-like receptor 3 recognition of viral RNAs produced in neighboring cellsHiromichi Dansako, Daisuke Yamane, Christoph Welsch, et al.
Bioinformatics (Oxford, England)|March 7, 2024
Graph-theoretical prediction of biological modules in quaternary structures of large protein complexesFlorian J Gisdon, Mariella Zunker, Jan Niclas Wolf, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 30, 2009
Highly sensitive determination of HCV protease inhibitors boceprevir (SCH 503034) and telaprevir (VX 950) in human plasma by LC-MS/MSHarald Farnik, Juliane El-Duweik, Christoph Welsch, et al.
Frontiers in Immunology|February 15, 2021
Translation of IRF-1 Restricts Hepatic Interleukin-7 Production to Types I and II Interferons: Implications for Hepatic ImmunitySabrina Rueschenbaum, Chengcong Cai, Matthias Schmidt, et al.
Pageof 10

Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
Bio Systems|August 13, 2025
Computational analysis of IL-6/IL-22 signaling in liver diseaseMarcus D Keßler, Lara Klemt, Marius Kirchner, et al.
The Journal of Clinical Endocrinology and Metabolism|November 27, 2020
Salt-Losing 21-Hydroxylase Deficiency Caused by Double Homozygosity for Two "Mild" MutationsJacob Ilany, Jiayan Liu, Christoph Welsch, et al.
BMC Endocrine Disorders|March 15, 2022
Distinct clinical phenotypes in a family with a novel truncating MEN1 frameshift mutationChristoph Welsch, Anna Katharina Flügel, Susanne Rondot, et al.
Gastroenterology|November 9, 2010
Protease inhibitor-resistant hepatitis C virus mutants with reduced fitness from impaired production of infectious virusTetsuro Shimakami, Christoph Welsch, Daisuke Yamane, et al.
Scientific Reports|January 21, 2016
Natural HCV variants with increased replicative fitness due to NS3 helicase mutations in the C-terminal helix α18Claudia Stross, Tetsuro Shimakami, Katrin Haselow, et al.
Antimicrobial Agents and Chemotherapy|January 19, 2012
Ketoamide resistance and hepatitis C virus fitness in val55 variants of the NS3 serine proteaseChristoph Welsch, Sabine Schweizer, Tetsuro Shimakami, et al.
Plos Pathogens|May 30, 2013
Class A scavenger receptor 1 (MSR1) restricts hepatitis C virus replication by mediating toll-like receptor 3 recognition of viral RNAs produced in neighboring cellsHiromichi Dansako, Daisuke Yamane, Christoph Welsch, et al.
Bioinformatics (Oxford, England)|March 7, 2024
Graph-theoretical prediction of biological modules in quaternary structures of large protein complexesFlorian J Gisdon, Mariella Zunker, Jan Niclas Wolf, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 30, 2009
Highly sensitive determination of HCV protease inhibitors boceprevir (SCH 503034) and telaprevir (VX 950) in human plasma by LC-MS/MSHarald Farnik, Juliane El-Duweik, Christoph Welsch, et al.
Frontiers in Immunology|February 15, 2021
Translation of IRF-1 Restricts Hepatic Interleukin-7 Production to Types I and II Interferons: Implications for Hepatic ImmunitySabrina Rueschenbaum, Chengcong Cai, Matthias Schmidt, et al.
Pageof 10